Identification of a transcription factor-microRNA network in esophageal adenocarcinoma through bioinformatics analysis and validation through qRT-PCR

References

• De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol. 2014;15(1):23–34. doi:10.1016/S1470-2045(13)70546-124314615
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.2133226742998
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Coleman HG, Xie SH, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology. 2018;154(2):390–405. doi:10.1053/j.gastro.2017.07.04628780073
   PubMed Web of Science ®Google Scholar
• Edgren G, Adami HO, Weiderpass E, Nyren O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62(10):1406–1414. doi:10.1136/gutjnl-2012-30241222917659
   PubMed Web of Science ®Google Scholar
• Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013;63(4):232–248. doi:10.3322/caac.2118523818335
   PubMed Web of Science ®Google Scholar
• Gavin AT, Francisci S, Foschi R, et al. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36(6):505–512. doi:10.1016/j.canep.2012.07.00922910036
   PubMed Web of Science ®Google Scholar
• Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis. J Gastroenterol Hepatol. 2016;31(6):1141–1146. doi:10.1111/jgh.1328926749521
   PubMed Web of Science ®Google Scholar
• Launoy G, Bossard N, Castro C, Manfredi S; Group GE-W. Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study. Eur Cancer Prev. 2017;26:S24–S31. Trends in cancer net survival in six European Latin Countries: the SUDCAN study. doi:10.1097/CEJ.0000000000000308
   Web of Science ®Google Scholar
• Hughes TR. Introduction to “a handbook of transcription factors”. Subcell Biochem. 2011;52:1–6. doi:10.1007/978-90-481-9069-0_121557076
   PubMedGoogle Scholar
• Bhagwat AS, Vakoc CR. Targeting transcription factors in cancer. Trends Cancer. 2015;1(1):53–65. doi:10.1016/j.trecan.2015.07.00126645049
   PubMed Web of Science ®Google Scholar
• Doench JG, Sharp PA. Specificity of microRNA target selection in translational repression. Genes Dev. 2004;18(5):504–511. doi:10.1101/gad.118440415014042
   PubMed Web of Science ®Google Scholar
• Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012;149(3):515–524. doi:10.1016/j.cell.2012.04.00522541426
   PubMed Web of Science ®Google Scholar
• Mangalhara KC, Manvati S, Saini SK, et al. ERK2-ZEB1-miR-101-1 axis contributes to epithelial–mesenchymal transition and cell migration in cancer. Cancer Lett. 2017;391:59–73. doi:10.1016/j.canlet.2017.01.01628109909
   PubMed Web of Science ®Google Scholar
• Hua S, Lei L, Deng L, et al. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene. 2018;285(3):1060–1061.
   Google Scholar
• Sun Y, Yang Z, Zheng B, et al. A novel regulatory mechanism of smooth muscle alpha-actin expression by NRG-1/circACTA2/miR-548f-5p axis. Circ Res. 2017;121(6):628–635. doi:10.1161/CIRCRESAHA.117.31144128698179
   PubMed Web of Science ®Google Scholar
• Guo Q, He Y, Sun L, et al. Identification of potential prognostic TF-associated lncRNAs for predicting survival in ovarian cancer. J Cell Mol Med. 2019;23(3):1840–1851. doi:10.1111/jcmm.1408430549251
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv00725605792
   PubMed Web of Science ®Google Scholar
• Han H, Cho JW, Lee S, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46(D1):D380–D386. doi:10.1093/nar/gkx101329087512
   PubMed Web of Science ®Google Scholar
• Jiang C, Xuan Z, Zhao F, Zhang MQ. TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res. 2007;35(Database):D137–D140. doi:10.1093/nar/gkl104117202159
   PubMedGoogle Scholar
• Chou CH, Shrestha S, Yang CD, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296–D302. doi:10.1093/nar/gkx106729126174
   PubMed Web of Science ®Google Scholar
• Huang Da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.21119131956
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447–D452. doi:10.1093/nar/gku100325352553
   PubMed Web of Science ®Google Scholar
• Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.12525261
   PubMed Web of Science ®Google Scholar
• Sodani K, Patel A, Kathawala RJ, Chen ZS. Multidrug resistance associated proteins in multidrug resistance. Chin J Cancer. 2012;31(2):58–72. doi:10.5732/cjc.011.1032922098952
   PubMed Web of Science ®Google Scholar
• Zhao Y, Lu H, Yan A, et al. ABCC3 as a marker for multidrug resistance in non-small cell lung cancer. Sci Rep. 2013;3:3120. doi:10.1038/srep0312024176985
   PubMed Web of Science ®Google Scholar
• Liu X, Yao D, Liu C, et al. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients. Tumour Biol. 2016;37(6):8367–8374. doi:10.1007/s13277-015-4703-526733163
   PubMedGoogle Scholar
• Ding X, Wang K, Wang H, et al. High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection. J gastrointestinal surg. 2012;16(4):828–836. doi:10.1007/s11605-011-1775-4
   PubMed Web of Science ®Google Scholar
• Sutherland A, Mirjolet JF, Maho A, Parmentier M. Expression of the chemokine receptor CCR6 in the Lewis lung carcinoma (LLC) cell line reduces its metastatic potential in vivo. Cancer Gene Ther. 2007;14(10):847–857. doi:10.1038/sj.cgt.770107417599091
   PubMed Web of Science ®Google Scholar
• Giuliani N, Lisignoli G, Colla S, et al. CC-chemokine ligand 20/macrophage inflammatory protein-3alpha and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions. Cancer Res. 2008;68(16):6840–6850. doi:10.1158/0008-5472.CAN-08-040218703490
   PubMed Web of Science ®Google Scholar
• Liu JY, Li F, Wang LP, et al. CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma. Br J Cancer. 2015;113(5):747–755. doi:10.1038/bjc.2015.29026284335
   PubMed Web of Science ®Google Scholar
• Wang GZ, Cheng X, Li XC, et al. Tobacco smoke induces production of chemokine CCL20 to promote lung cancer. Cancer Lett. 2015;363(1):60–70. doi:10.1016/j.canlet.2015.04.00525864589
   PubMed Web of Science ®Google Scholar
• Voronov E, Dotan S, Krelin Y, et al. Unique versus redundant functions of IL-1alpha and IL-1beta in the tumor microenvironment. Front Immunol. 2013;4:177. doi:10.3389/fimmu.2013.0017723847618
   PubMed Web of Science ®Google Scholar
• Ishihara T, Seki N, Inoguchi S, et al. Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma. J Urol. 2014;192(6):1822–1830. doi:10.1016/j.juro.2014.07.00125014580
   PubMed Web of Science ®Google Scholar
• Li W, Liu Z, Chen L, Zhou L, Yao Y. MicroRNA-23b is an independent prognostic marker and suppresses ovarian cancer progression by targeting runt-related transcription factor-2. FEBS Lett. 2014;588(9):1608–1615. doi:10.1016/j.febslet.2014.02.05524613919
   PubMed Web of Science ®Google Scholar
• Peng WZ, Ma R, Wang F, Yu J, Liu ZB. Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer. Int J Mol Sci. 2014;15(3):4031–4048. doi:10.3390/ijms1503403124603541
   PubMed Web of Science ®Google Scholar
• Elyakim E, Sitbon E, Faerman A, et al. hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res. 2010;70(20):8077–8087. doi:10.1158/0008-5472.CAN-10-131320924108
   PubMed Web of Science ®Google Scholar
• Liu H, Xu XF, Zhao Y, et al. MicroRNA-191 promotes pancreatic cancer progression by targeting USP10. Tumour Biol. 2014;35(12):12157–12163. doi:10.1007/s13277-014-2521-925168367
   PubMedGoogle Scholar